Effect of Ginseng on Glycemic Control
Mo kle
Abstrè
Deskripsyon
Ginseng has demonstrated to have significant hypoglycemic effect. Its major pharmacological component is considered to be ginsenosides. Several trials have been undertaken in diabetes some of which have demonstrated advantages in glycemic control in both diabetic as well as non diabetic individuals although clinical consistency of results is lacking.The lack of high quality data in this area to support diabetes recommendations represents an urgent call for stronger evidence. A systematic review and meta-analysis of controlled trials remains the "Gold Standard" of evidence for recommendations and clinical guidelines development. Therefore, investigators will conduct a systematic review and meta-analyses of controlled trials to assess the effect of ginseng on glycemic control.
Dat
| Dènye verifye: | 04/30/2013 |
| Premye Soumèt: | 04/22/2013 |
| Enskripsyon Estimasyon Soumèt: | 04/24/2013 |
| Premye afiche: | 04/25/2013 |
| Dènye Mizajou Soumèt: | 05/21/2013 |
| Dènye Mizajou afiche: | 05/22/2013 |
| Dat aktyèl kòmanse etid la: | 09/30/2012 |
| Dat Estimasyon Prensipal Estimasyon an: | 04/30/2013 |
| Dat estime fini etid la: | 04/30/2013 |
Kondisyon oswa maladi
Faz
Kritè kalifikasyon yo
| Sèks ki kalifye pou etid | All |
| Metòd echantiyonaj | Probability Sample |
| Aksepte Volontè Healthy | Wi |
| Kritè | Inclusion Criteria: - Dietary trials in humans - Randomized treatment allocation - 1 month - Suitable control - Viable endpoint data Exclusion Criteria: - Non-human studies - Non-randomized treatment allocation - <1 month - Lack of a suitable control - No viable endpoint data |
Rezilta
Mezi Rezilta Prensipal yo
1. Glycated hemoglobin (HbA1c) [1month]
Mezi Rezilta Segondè
1. Fasting blood glucose [1month]
2. Fasting plasma insulin [1 month]
3. Homeostasis model assessment of insulin resistance (HOMA-IR) [1 month]
